학술논문
Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC
Document Type
Article
Author
Source
In European Journal of Cancer January 2024 196
Subject
Language
ISSN
0959-8049